| Brand | Exbio | 
| Product type | Primary antibodies | 
| Reactivity | Human | 
| Clonality | Monoclonal | 
| Brand: | Exbio | 
| Product no.: | 11-154-C025 | 
| Product type: | Primary antibodies | 
| Host species: | Mouse | 
| Product name: | Mouse Monoclonal to CD70 | 
| Antigen: | CD70 | 
| Clonality: | Monoclonal | 
| Clone: | Ki-24 | 
| Isotype: | IgG3 | 
| Format: | purified | 
| Specificity: | The mouse monoclonal antibody Ki-24 recognizes CD70, an approximately 50 kDa type II transmembrane glycoprotein expressed on activated lymphocytes and some B cell leukemias._x000D_ _x000D_  _x000D_ Workshop Code: IV A109  | 
| Categories: | CD and Related Antigens (Human) | 
| Concentration: | 1 mg/ml | 
| Storage buffer: | Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4 | 
| Storage / stability: | Store at 2-8°C. Do not freeze. Do not use after expiration date stamped on vial label. | 
| Background: | CD70, also known as TNFSF7 or CD27L, is a 50 kDa type II transmembrane glycoprotein of the TNF superfamily. It is expressed mainly on activated lymphocytes, including NK cells, and forms trimeric structure. CD70 plays a role in T-cell activation, proliferation and differentiation, in enhancing the generation of cytolytic T cells, and in long-term maintenance of T cell memory. It is also involved in B cell differentiation induced by activated plasmacytoid dendritic cells, which also express CD70. | 
| Purity: | > 95% (by SDS-PAGE) | 
| Purification: | Purified by protein-A affinity chromatography | 
| Product specific references: | *Hashimoto-Okada M, Kitawaki T, Kadowaki N, Iwata S, Morimoto C, Hori T, Uchiyama T: The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans. Int Immunol. 2009 Aug;21(8):891-904., Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma. J Immunol. 2005 Nov 15;175(10):6940-7., *Israel BF, Pickles RJ, Segal DM, Gerard RD, Kenney SC: Enhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibody. J Virol. 2001 Jun;75(11):5215-21., *Trebing J, El-Mesery M, Schäfer V, Weisenberger D, Siegmund D, Silence K, Wajant H. CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants. Cell Death Dis. 2014 Jan 30;5:e1035., *Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma. J Immunol. 2005 Nov 15;175(10):6940-7. | 
| Related products: | - Mouse Monoclonal to CD79a - Mouse Monoclonal to CD71 / Transferrin Receptor - Mouse Monoclonal to CD73  | 
| Shipping condition: | Room temperature |